Ibrahim T - Search Results

1

An in-silico study of cancer cell survival and spatial distribution within a 3D microenvironment.

Cortesi M, Liverani C, Mercatali L, Ibrahim T, Giordano E. Cortesi M, et al. Among authors: ibrahim t. Sci Rep. 2020 Jul 31;10(1):12976. doi: 10.1038/s41598-020-69862-7. Sci Rep. 2020. PMID: 32737377 Free PMC article.

2

Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study.

Ibrahim T, Barbanti F, Giorgio-Marrano G, Mercatali L, Ronconi S, Vicini C, Amadori D. Ibrahim T, et al. Oncologist. 2008 Mar;13(3):330-6. doi: 10.1634/theoncologist.2007-0159. Oncologist. 2008. PMID: 18378544 Free article.

3

Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational model.

Ibrahim T, Flamini E, Fabbri L, Serra P, Mercatali L, Ricci R, Sacanna E, Falasconi MC, Casadei R, Galassi R, Giannini M, Bazzocchi O, Calzolari F, Nunziatini R, Gaudio M, Maltoni M, Amadori D. Ibrahim T, et al. Tumori. 2009 May-Jun;95(3):291-7. doi: 10.1177/030089160909500304. Tumori. 2009. PMID: 19688966

4

Pathogenesis of osteoblastic bone metastases from prostate cancer.

Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D. Ibrahim T, et al. Cancer. 2010 Mar 15;116(6):1406-18. doi: 10.1002/cncr.24896. Cancer. 2010. PMID: 20108337 Free article. Review.

5

Time-dependent pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer.

Ibrahim T, Di Paolo A, Amatori F, Mercatali L, Ravaioli E, Flamini E, Sacanna E, Del Tacca M, Danesi R, Amadori D. Ibrahim T, et al. J Clin Pharmacol. 2012 Mar;52(3):361-9. doi: 10.1177/0091270010396710. Epub 2011 Mar 7. J Clin Pharmacol. 2012. PMID: 21383342 Clinical Trial.

6

Bone metastases detection by circulating biomarkers: OPG and RANK-L.

Mercatali L, Ibrahim T, Sacanna E, Flamini E, Scarpi E, Calistri D, Ricci M, Serra P, Ricci R, Zoli W, Kang Y, Amadori D. Mercatali L, et al. Among authors: ibrahim t. Int J Oncol. 2011 Jul;39(1):255-61. doi: 10.3892/ijo.2011.1001. Epub 2011 Apr 13. Int J Oncol. 2011. PMID: 21491082

7

The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study.

Sacanna E, Ibrahim T, Gaudio M, Mercatali L, Scarpi E, Zoli W, Serra P, Bravaccini S, Ricci R, Serra L, Amadori D. Sacanna E, et al. Among authors: ibrahim t. Oncology. 2011;80(3-4):225-31. doi: 10.1159/000327585. Epub 2011 Jul 5. Oncology. 2011. PMID: 21734413

8

Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.

Ibrahim T, Sacanna E, Gaudio M, Mercatali L, Scarpi E, Zoli W, Serra P, Ricci R, Serra L, Kang Y, Amadori D. Ibrahim T, et al. Clin Breast Cancer. 2011 Dec;11(6):369-75. doi: 10.1016/j.clbc.2011.05.001. Epub 2011 Jul 20. Clin Breast Cancer. 2011. PMID: 21764390

9

Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.

Chakrabarti R, Hwang J, Andres Blanco M, Wei Y, Lukačišin M, Romano RA, Smalley K, Liu S, Yang Q, Ibrahim T, Mercatali L, Amadori D, Haffty BG, Sinha S, Kang Y. Chakrabarti R, et al. Among authors: ibrahim t. Nat Cell Biol. 2012 Nov;14(11):1212-22. doi: 10.1038/ncb2607. Epub 2012 Oct 21. Nat Cell Biol. 2012. PMID: 23086238 Free PMC article.

10

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.

Ibrahim T, Mercatali L, Sacanna E, Tesei A, Carloni S, Ulivi P, Liverani C, Fabbri F, Zanoni M, Zoli W, Amadori D. Ibrahim T, et al. Cancer Cell Int. 2012 Nov 22;12(1):48. doi: 10.1186/1475-2867-12-48. Cancer Cell Int. 2012. PMID: 23173568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,056 results

Search Page